HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways

Qing Li(Jiangsu Province Hospital), Kangsheng Tu(First Affiliated Hospital of Xi'an Jiaotong University)
Journal of Experimental & Clinical Cancer Research
September 19, 2018
Cited by 156


Related Papers